Emory-discovered antiviral is poised for COVID-19 clinical trials
Thursday, March 26, 2020 - 19:31
in Health & Medicine
The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans
The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans